{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:43:18Z","timestamp":1768837398301,"version":"3.49.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023334","name":"Fondation des Etoiles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jlr.2025.100787","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T01:26:22Z","timestamp":1743297982000},"page":"100787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations between plasma 24(S)-hydroxycholesterol and neuropsychological profile in fragile X syndrome"],"prefix":"10.1016","volume":"66","author":[{"given":"Asma","family":"Laroui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Bouhour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lodie","family":"Proteau-Lemieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1871-9331","authenticated-orcid":false,"given":"Luc","family":"Galarneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3166-1883","authenticated-orcid":false,"given":"S\u00e9rine","family":"Benachenhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0732-2996","authenticated-orcid":false,"given":"Armita","family":"Abolghasemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalie","family":"Plantefeve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7500-1992","authenticated-orcid":false,"given":"Pierre-Luc","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-5897","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Corbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artuela","family":"\u00c7aku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2025.100787_bib1","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/ajmg.a.36511","article-title":"Epidemiology of fragile X syndrome: a systematic review and meta-analysis","volume":"164","author":"Hunter","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.jlr.2025.100787_bib2","first-page":"463","article-title":"Genetic mapping of DNA segments relative to the locus for the fragile-X syndrome at Xq27.3","volume":"37","author":"Mulligan","year":"1985","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jlr.2025.100787_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000758","article-title":"A mouse model of the human fragile x syndrome I304n mutation","volume":"5","author":"Zang","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jlr.2025.100787_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jlr.2025.100787_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molmet.2019.01.002","article-title":"The translational regulator FMRP controls lipid and glucose metabolism in mice and humans","volume":"21","author":"Leboucher","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.jlr.2025.100787_bib6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1352\/1944-7558-115.6.482","article-title":"Obesity, food selectivity, and physical activity in individuals with fragile X syndrome","volume":"115","author":"Raspa","year":"2010","journal-title":"Am. J. Intellect. Dev. Disabilities"},{"key":"10.1016\/j.jlr.2025.100787_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ajmg.a.36850","article-title":"Cholesterol levels in fragile X syndrome","volume":"167A","author":"Berry-Kravis","year":"2015","journal-title":"Am. J. Med. Genet. A."},{"key":"10.1016\/j.jlr.2025.100787_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174301","article-title":"New insights of altered lipid profile in fragile X syndrome","volume":"12","author":"\u00c7aku","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2025.100787_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/157016111794519354","article-title":"Hypocholesterolemia","volume":"9","author":"Moutzouri","year":"2011","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.jlr.2025.100787_bib10","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1073\/pnas.0600316103","article-title":"Brain cholesterol turnover required for geranylgeraniol production and learning in mice","volume":"103","author":"Kotti","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2025.100787_bib11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s13311-019-00731-6","article-title":"Cholesterol 24-hydroxylation by CYP46A1: benefits of modulation for brain diseases","volume":"16","author":"Petrov","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jlr.2025.100787_bib12","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.bmc.2016.04.024","article-title":"Synthesis of 24(S)-hydroxycholesterol esters responsible for the induction of neuronal cell death","volume":"24","author":"Shibuya","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jlr.2025.100787_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","article-title":"Cholesterol metabolism and homeostasis in the brain","volume":"6","author":"Zhang","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.jlr.2025.100787_bib14","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1021\/pr7006076","article-title":"The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron proteome","volume":"7","author":"Wang","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jlr.2025.100787_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1194\/jlr.M300320-JLR200","article-title":"Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer\u2019s disease","volume":"45","author":"Heverin","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2025.100787_bib16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1194\/jlr.M500024-JLR200","article-title":"Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain","volume":"46","author":"Heverin","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2025.100787_bib17","doi-asserted-by":"crossref","first-page":"842814","DOI":"10.3389\/fnins.2022.842814","article-title":"Connecting the dots between hypercholesterolemia and Alzheimer\u2019s disease: a potential mechanism based on 27-hydroxycholesterol","volume":"16","author":"Wu","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jlr.2025.100787_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.chemphyslip.2016.03.001","article-title":"Cholesterol oxidation products and their biological importance","volume":"199","author":"Kulig","year":"2016","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.jlr.2025.100787_bib19","series-title":"Biochemistry, Cholesterol. in StatPearls","author":"Craig","year":"2021"},{"key":"10.1016\/j.jlr.2025.100787_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69454-5","article-title":"Cholesterol modulates presynaptic and postsynaptic properties of excitatory synaptic transmission","volume":"10","author":"Korinek","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2025.100787_bib21","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1113\/jphysiol.2014.288209","article-title":"Cholesterol modulates open probability and desensitization of NMDA receptors","volume":"593","author":"Korinek","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.jlr.2025.100787_bib22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1528-1157.2000.tb01499.x","article-title":"Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome","volume":"41","author":"Musumeci","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.jlr.2025.100787_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2004.11.087","article-title":"Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse","volume":"377","author":"El Idrissi","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jlr.2025.100787_bib24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1469-8749.2002.tb00277.x","article-title":"Epilepsy in fragile X syndrome","volume":"44","author":"Berry-Kravis","year":"2002","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.jlr.2025.100787_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fnint.2019.00060","article-title":"Auditory EEG biomarkers in fragile X syndrome: clinical relevance","volume":"13","author":"Ethridge","year":"2019","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.jlr.2025.100787_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13229-017-0140-1","article-title":"Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome","volume":"8","author":"Ethridge","year":"2017","journal-title":"Mol. Autism"},{"key":"10.1016\/j.jlr.2025.100787_bib27","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41419-021-03776-8","article-title":"Novel fragile X syndrome 2D and 3D brain models based on human isogenic FMRP-KO iPSCs","volume":"12","author":"Brighi","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jlr.2025.100787_bib28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41398-019-0650-z","article-title":"Hyperexcitability and impaired intracortical inhibition in patients with fragile-X syndrome","volume":"9","author":"Morin-Parent","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jlr.2025.100787_bib29","first-page":"26","article-title":"Transcranial magnetic stimulation provides means to assess cortical plasticity and excitability in humans with fragile X syndrome and autism spectrum disorder","volume":"2","author":"Oberman","year":"2010","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.jlr.2025.100787_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41514-021-00064-9","article-title":"Abnormal brain cholesterol homeostasis in Alzheimer's disease\u2014a targeted metabolomic and transcriptomic study","volume":"7","author":"Varma","year":"2021","journal-title":"Npj Aging Mech. Dis."},{"key":"10.1016\/j.jlr.2025.100787_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nbd.2013.03.013","article-title":"Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression","volume":"55","author":"Leoni","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jlr.2025.100787_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3940(02)00887-X","article-title":"Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis","volume":"331","author":"Leoni","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jlr.2025.100787_bib33","article-title":"The safety and efficacy of metformin in fragile X syndrome: an open-label study","volume":"110","author":"Proteauux-Lemie","year":"2021","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jlr.2025.100787_bib34","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1399-0004.2011.01798.x","article-title":"Quantitative measurement of FMRP in blood platelets as a new screening test for fragile X syndrome","volume":"82","author":"Lessard","year":"2012","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jlr.2025.100787_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106408","article-title":"Development and validation of a liquid chromatography-tandem mass spectrometry assay to quantify plasma 24(S)-hydroxycholesterol and 27-hydroxycholesterol: a new approach integrating the concept of ion ratio","volume":"235","author":"Rojas","year":"2023","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jlr.2025.100787_bib36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.clinph.2020.10.003","article-title":"Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: expert Guidelines","volume":"132","author":"Rossi","year":"2021","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jlr.2025.100787_bib37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/brainsci11060682","article-title":"Polish adaptation of the social communication questionnaire (SCQ) and female autism phenotype: an investigation of potentially sex-biased items in the screening assessment and their impact on scores","volume":"11","author":"Rynkiewicz","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.jlr.2025.100787_bib38","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1007\/s10803-018-3566-1","article-title":"Social Responsiveness Scale (SRS) in relation to longitudinal cortical thickness changes in autism spectrum disorder","volume":"48","author":"Prigge","year":"2018","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.jlr.2025.100787_bib39","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/aur.1813","article-title":"Validating the social responsiveness scale for adults with autism","volume":"10","author":"Chan","year":"2017","journal-title":"Autism Res."},{"key":"10.1016\/j.jlr.2025.100787_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11689-010-9067-y","article-title":"Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization","volume":"3","author":"Cordeiro","year":"2011","journal-title":"J. Neurodevelop Disord."},{"key":"10.1016\/j.jlr.2025.100787_bib41","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/aur.2159","article-title":"Psychometric analysis of the repetitive behavior scale-revised using confirmatory factor analysis in children with autism","volume":"12","author":"Hooker","year":"2019","journal-title":"Autism Res."},{"key":"10.1016\/j.jlr.2025.100787_bib42","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10803-011-1370-2","article-title":"Psychometric study of the aberrant behavior checklist in fragile X syndrome and implications for targeted treatment","volume":"42","author":"Sansone","year":"2012","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.jlr.2025.100787_bib43","first-page":"485","article-title":"The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects","volume":"89","author":"Aman","year":"1985","journal-title":"Am. J. Ment. Defic"},{"key":"10.1016\/j.jlr.2025.100787_bib44","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/1352458516666187","article-title":"Interdependence of oxysterols with cholesterol profiles in multiple sclerosis","volume":"23","author":"Mukhopadhyay","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jlr.2025.100787_bib45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3233\/JHD-240030","article-title":"Changes in 24(s)-hydroxycholesterol are associated with cognitive performance in early huntington's disease: data from the TRACK and ENROLL HD cohorts","volume":"13","author":"Gray","year":"2024","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.jlr.2025.100787_bib46","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.3390\/ijms23063408","article-title":"Brain cholesterol biosynthetic pathway is altered in a preclinical model of fragile X syndrome","volume":"23","author":"Parente","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2025.100787_bib47","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s42003-023-05147-9","article-title":"An iPSC-derived astrocyte model of fragile X syndrome exhibits dysregulated cholesterol homeostasis","volume":"6","author":"Talvio","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jlr.2025.100787_bib48","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","article-title":"Liver X receptors in lipid signalling and membrane homeostasis","volume":"14","author":"Wang","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jlr.2025.100787_bib49","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.3390\/ijms20163858","article-title":"Regulation of brain cholesterol: what role do liver x receptors play in neurodegenerative diseases?","volume":"20","author":"Mouzat","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2025.100787_bib50","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/glia.24331","article-title":"Dysregulated cholesterol metabolism, aberrant excitability and altered cell cycle of astrocytes in fragile X syndrome","volume":"71","author":"Ren","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.jlr.2025.100787_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41583-021-00432-0","article-title":"The molecular biology of fmrp: new insights into fragile X syndrome","volume":"22","author":"Richter","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jlr.2025.100787_bib52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01725.x","article-title":"Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain","volume":"260","author":"Bj\u00f6rkhem","year":"2006","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jlr.2025.100787_bib53","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0022-2275(20)32393-2","article-title":"Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface","volume":"41","author":"Bretillon","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2025.100787_bib54","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/jn\/135.4.681","article-title":"Sexual dimorphism in human lipid metabolism","volume":"135","author":"Mittendorfer","year":"2005","journal-title":"J. Nutr."},{"key":"10.1016\/j.jlr.2025.100787_bib55","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41537-020-00121-4","article-title":"Assessment of brain cholesterol metabolism biomarker 24S-hydroxycholesterol in schizophrenia","volume":"6","author":"Chiappelli","year":"2020","journal-title":"NPJ Schizophr."},{"key":"10.1016\/j.jlr.2025.100787_bib56","first-page":"131","article-title":"Cortical excitability and neurology: insights into the pathophysiology","volume":"27","author":"Badawy","year":"2012","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.jlr.2025.100787_bib57","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1113\/jphysiol.2007.142059","article-title":"Inhibitory circuits and the nature of their interactions in the human motor cortex \u2013 a pharmacological TMS study","volume":"586","author":"M\u00fcller-Dahlhaus","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.jlr.2025.100787_bib58","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/sj.bjp.0704360","article-title":"Influence of membrane cholesterol on modulation of the GABA(A) receptor by neuroactive steroids and other potentiators","volume":"134","author":"Sooksawate","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jlr.2025.100787_bib59","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1038\/s41598-022-07064-z","article-title":"Association of lipid rafts cholesterol with clinical profile in fragile X syndrome","volume":"12","author":"Toupin","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2025.100787_bib60","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1542\/peds.2016-1159F","article-title":"Autism spectrum disorder in fragile X syndrome: cooccurring conditions and current treatment","volume":"139","author":"Kaufmann","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.jlr.2025.100787_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/aur.2183","article-title":"Implication of hypocholesterolemia in autism spectrum disorder and its associated comorbidities: a retrospective case-control study","author":"Benachenhou","year":"2019","journal-title":"Autism Res."},{"key":"10.1016\/j.jlr.2025.100787_bib62","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biochi.2018.04.026","article-title":"Plasma oxysterol profiling in children reveals 24-hydroxycholesterol as a potential marker for Autism Spectrum Disorders","volume":"153","author":"Grayaa","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.jlr.2025.100787_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.105902","article-title":"Plasma oxysterols: Altered level of plasma 24-hydroxycholesterol in patients with bipolar disorder","volume":"211","author":"Guidara","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227525000471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227525000471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T15:25:53Z","timestamp":1752679553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227525000471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0022227525000471"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2025.100787","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between plasma 24(S)-hydroxycholesterol and neuropsychological profile in fragile X syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2025.100787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"100787"}}